• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BLOCK DRUG CO., INC. COREGA TABS 3 MINUTEN; DENTURE CLEANSER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BLOCK DRUG CO., INC. COREGA TABS 3 MINUTEN; DENTURE CLEANSER Back to Search Results
Lot Number MH141724A
Device Problem Insufficient Information (3190)
Patient Problems High Blood Pressure/ Hypertension (1908); Thrombosis (2100)
Event Type  Injury  
Manufacturer Narrative
The 1020379-2018-00020 is associated with argus case (b)(4), corega tabs 3 minuten.Corega tabs 3 minuten is marketed as polident in the us.
 
Event Description
Thrombosis.Cholesterol.Hypertension.Osteoporosis.Case description: this case was reported by a consumer via call center representative and described the occurrence of thrombosis in a female patient who received double salt denture cleanser (corega tabs 3 minuten) tablet (batch number mh141724a, expiry date august 2019) for prosthesis user.This case was associated with a product complaint.On an unknown date, the patient started corega tabs 3 minuten.On an unknown date, an unknown time after starting corega tabs 3 minuten, the patient experienced thrombosis (serious criteria gsk medically significant), cholesterol, hypertension, osteoporosis and product complaint.The action taken with corega tabs 3 minuten was unknown.On an unknown date, the outcome of the thrombosis was not reported and the outcome of the cholesterol, hypertension, osteoporosis and product complaint were unknown.It was unknown if the reporter considered the thrombosis, cholesterol, hypertension and osteoporosis to be related to corega tabs 3 minuten.This report is made by gsk without prejudice and does not imply any admission or liability for the incident or its consequences.Additional details, the consumer informed the patient could not go to the street because she had thrombosis in both legs.She said she used corega for more than 15 years and the thrombosis appeared short time ago.She also said she would given the list of all the medicines she taken.She taken remedy for thrombosis, for cholesterol, for hypertension and for osteoporosis.So, she did not specified which medicines she had been taken.
 
Event Description
Case description: this case was reported by a consumer via call center representative and described the occurrence of thrombosis in a female patient who received double salt denture cleanser (corega tabs 3 minuten) tablet (batch number mh141724a, expiry date august 2019) for prosthesis user.This case was associated with a product complaint.On an unknown date, the patient started corega tabs 3 minuten.On an unknown date, an unknown time after starting corega tabs 3 minuten, the patient experienced thrombosis (serious criteria gsk medically significant), cholesterol, hypertension, osteoporosis and product complaint.The action taken with corega tabs 3 minuten was unknown.On an unknown date, the outcome of the thrombosis was not reported and the outcome of the cholesterol, hypertension, osteoporosis and product complaint were unknown.It was unknown if the reporter considered the thrombosis, cholesterol, hypertension and osteoporosis to be related to corega tabs 3 minuten.This report is made by gsk without prejudice and does not imply any admission or liability for the incident or its consequences.Additional details, the consumer informed the patient could not go to the street because she had thrombosis in both legs.She said she used corega for more than 15 years and the thrombosis appeared short time ago.She also said she would given the list of all the medicines she taken.She taken remedy for thrombosis, for cholesterol, for hypertension and for osteoporosis.So, she did not specified which medicines she had been taken.Follow up information was received for correction on 19 mar 2018, the initial case was opened the product complaint by call center, but this investigation it was not related to adverse event.Therefore, the event product complaint should not had been added for this case, so would exclude the event product complaint.
 
Manufacturer Narrative
1020379-2018-00020 is associated with argus case (b)(4), corega tabs 3 minuten.Corega tabs 3 minuten is marketed as polident in the us.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COREGA TABS 3 MINUTEN
Type of Device
DENTURE CLEANSER
Manufacturer (Section D)
BLOCK DRUG CO., INC.
2149 harbor avenue
memphis TN 38113
MDR Report Key7375589
MDR Text Key103657462
Report Number1020379-2018-00020
Device Sequence Number1
Product Code EFT
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Type of Report Initial,Followup
Report Date 03/19/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/27/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date08/31/2019
Device Lot NumberMH141724A
Date Manufacturer Received03/19/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-